Skip to main content
Erschienen in: Wiener klinische Wochenschrift 23-24/2012

01.12.2012 | case report

Clinically symptomatic heterozygous carnitine palmitoyltransferase II (CPT II) deficiency

verfasst von: Dr. Pushpa Raj Joshi, PhD, Marcus Deschauer, MD, Stephan Zierz, MD

Erschienen in: Wiener klinische Wochenschrift | Ausgabe 23-24/2012

Einloggen, um Zugang zu erhalten

Summary

Two symptomatic patients with heterozygous carnitine palmitoyltransferase II (CPT II) deficiency are reported. Patient 1, a 21-year-old female professional tennis player, suffered from exercise-induced attacks of muscle pain, burning sensations and proximal weakness. Patient 2, a 30-year-old male amateur marathon runner developed muscle cramps and rhabdomyolysis upon extensive exercise and insolation-induced fever. In both patients, the common p.S113L mutation was found in heterozygote state. No second mutation could be found upon sequencing of all the exons of CPT2 gene including exon–intron boundaries. Biochemically, residual CPT activity in muscle homogenate upon inhibition by malonyl-CoA and Triton-X-100 was intermediate between controls and patients with mutations on both alleles. Although CPT II deficiency is an autosomal recessive disorder, the reported patients indicate that heterozygotes might also have typical attacks of myalgia, pareses or rhabdomyolysis.
Literatur
1.
Zurück zum Zitat Bonefont JP, Demaugre F, Prip-Buss C, et al. Carnitine palmitoyltransferase deficiencies. Mol Genet Metab. 1999;68:424–40.CrossRef Bonefont JP, Demaugre F, Prip-Buss C, et al. Carnitine palmitoyltransferase deficiencies. Mol Genet Metab. 1999;68:424–40.CrossRef
2.
Zurück zum Zitat Wieser T, Deschauer M, Olek K, Hermann T, Zierz S. Carnitine palmitoyltransferase II deficiency: molecular and biochemical analysis of 32 patients. Neurology. 2003;60(8):1351–3.PubMedCrossRef Wieser T, Deschauer M, Olek K, Hermann T, Zierz S. Carnitine palmitoyltransferase II deficiency: molecular and biochemical analysis of 32 patients. Neurology. 2003;60(8):1351–3.PubMedCrossRef
3.
Zurück zum Zitat Deschauer M, Wieser T, Zierz S. Muscle carnitine palmitoyltransferase II deficiency: clinical and molecular genetic features and diagnostic aspects. Arch Neurol. 2005;62:37–41.PubMedCrossRef Deschauer M, Wieser T, Zierz S. Muscle carnitine palmitoyltransferase II deficiency: clinical and molecular genetic features and diagnostic aspects. Arch Neurol. 2005;62:37–41.PubMedCrossRef
4.
Zurück zum Zitat Finochhiaro G, Taroni F, Rocchi M, et al. cDNA cloning, sequence analysis, and chromosomal localisation of the gene for human carnitine palmitoyltransferase. Proc Natl Acad Sci U S A. 1991;88:661–5.CrossRef Finochhiaro G, Taroni F, Rocchi M, et al. cDNA cloning, sequence analysis, and chromosomal localisation of the gene for human carnitine palmitoyltransferase. Proc Natl Acad Sci U S A. 1991;88:661–5.CrossRef
5.
Zurück zum Zitat Taroni F, Verderio E, Dworzak F, et al. Identification of a common mutation in the carnitine palmitoyltransferase II gene in familial recurrent myoglobinuria patients. Nat Genet. 1993;4:314–9.PubMedCrossRef Taroni F, Verderio E, Dworzak F, et al. Identification of a common mutation in the carnitine palmitoyltransferase II gene in familial recurrent myoglobinuria patients. Nat Genet. 1993;4:314–9.PubMedCrossRef
6.
Zurück zum Zitat Zierz S, Engel AG, Olek K. The Ser113Leu mutation in the carnitine palmitoyltransferase deficiency. Muscle Nerve. 1994;(Suppl 1):129. Zierz S, Engel AG, Olek K. The Ser113Leu mutation in the carnitine palmitoyltransferase deficiency. Muscle Nerve. 1994;(Suppl 1):129.
7.
Zurück zum Zitat Deschauer M, Wieser T, Schröder R, Zierz S. A novel mutation (515del4) in muscle carnitine palmitoyltransferase II deficiency. Mol Genet Metab. 2002;75:181–5.PubMedCrossRef Deschauer M, Wieser T, Schröder R, Zierz S. A novel mutation (515del4) in muscle carnitine palmitoyltransferase II deficiency. Mol Genet Metab. 2002;75:181–5.PubMedCrossRef
8.
Zurück zum Zitat Isackson PJ, Benett MJ, Vladutiu GD. Identification of 16 new disease-causing mutations in CPT2 gene resulting in carnitine palmitoyltransferase II deficiency. Mol Genet Metab. 2006;89:323–1.PubMedCrossRef Isackson PJ, Benett MJ, Vladutiu GD. Identification of 16 new disease-causing mutations in CPT2 gene resulting in carnitine palmitoyltransferase II deficiency. Mol Genet Metab. 2006;89:323–1.PubMedCrossRef
9.
Zurück zum Zitat Orngreen MC, Duno M, Ejstrup R, et al. Fuel utilization in subjects with carnitine palmitoyltransferase 2 gene mutations. Ann Neurol. 2005;57:60–66.PubMedCrossRef Orngreen MC, Duno M, Ejstrup R, et al. Fuel utilization in subjects with carnitine palmitoyltransferase 2 gene mutations. Ann Neurol. 2005;57:60–66.PubMedCrossRef
10.
Zurück zum Zitat Vladutiu GD. Biochemical and molecular correlations in carnitine palmitoyltransferase II deficiency. Muscle Nerve. 1999;22:949–51.PubMedCrossRef Vladutiu GD. Biochemical and molecular correlations in carnitine palmitoyltransferase II deficiency. Muscle Nerve. 1999;22:949–51.PubMedCrossRef
11.
Zurück zum Zitat Taggart RT, Smail D, Apolito C, Vladutiu GD. Novel mutations associated with carnitine palmitoyltransferase II deficiency. Hum Mutat. 1999;13:210–20.PubMedCrossRef Taggart RT, Smail D, Apolito C, Vladutiu GD. Novel mutations associated with carnitine palmitoyltransferase II deficiency. Hum Mutat. 1999;13:210–20.PubMedCrossRef
12.
Zurück zum Zitat Anichini A, Fanin M, Vianey-Saban C, Cassandrini D, Fiorillo C, Bruno C, Angelini C. Genotype-phenotype correlations in a large series of patients with muscle type CPT II deficiency. Neurol Res. 2011;33(1):24–32.PubMedCrossRef Anichini A, Fanin M, Vianey-Saban C, Cassandrini D, Fiorillo C, Bruno C, Angelini C. Genotype-phenotype correlations in a large series of patients with muscle type CPT II deficiency. Neurol Res. 2011;33(1):24–32.PubMedCrossRef
13.
Zurück zum Zitat Rafay MF, Murphy EG, McGarry JD, Kaufmann P, DiMauro S, Tein I. Clinical and biochemical heterogeneity in an Italian family with CPT II deficiency due to Ser 113 Leu mutation. Can J Neurol Sci. 2005;32:316–20.PubMed Rafay MF, Murphy EG, McGarry JD, Kaufmann P, DiMauro S, Tein I. Clinical and biochemical heterogeneity in an Italian family with CPT II deficiency due to Ser 113 Leu mutation. Can J Neurol Sci. 2005;32:316–20.PubMed
14.
Zurück zum Zitat Thuillier L, Sevin C, Demaugre F, Brivet M, Rabier D, Droin V, Aupetit J, Abadi N, Kamoun P, Saudubray JM, Bonnefont JP. Genotype/phenotype correlation in carnitine palmitoyl transferase II deficiency: lessons from a compound heterozygous patient. Neuromuscul Disord. 2000;10(3):200–5.PubMedCrossRef Thuillier L, Sevin C, Demaugre F, Brivet M, Rabier D, Droin V, Aupetit J, Abadi N, Kamoun P, Saudubray JM, Bonnefont JP. Genotype/phenotype correlation in carnitine palmitoyl transferase II deficiency: lessons from a compound heterozygous patient. Neuromuscul Disord. 2000;10(3):200–5.PubMedCrossRef
15.
Zurück zum Zitat Zierz S, Engel AG. Regulatory properties of a mutant mutant carnitine pylmitoyltransferase in human skeletal muscle. Eur J Biochem. 1985;149:207–14.PubMedCrossRef Zierz S, Engel AG. Regulatory properties of a mutant mutant carnitine pylmitoyltransferase in human skeletal muscle. Eur J Biochem. 1985;149:207–14.PubMedCrossRef
16.
Zurück zum Zitat Zierz S, Mundegar RR, Jerusalem F. Biochemical evidence of heterozygosity in muscular carnitine palmitoyltransferase deficiency. Clin Investig. 1993;72:77–83.PubMedCrossRef Zierz S, Mundegar RR, Jerusalem F. Biochemical evidence of heterozygosity in muscular carnitine palmitoyltransferase deficiency. Clin Investig. 1993;72:77–83.PubMedCrossRef
17.
Zurück zum Zitat Lippi G, Schena F, Salvagno GL, Montagnana M, Gelati M, Tarperi C, Banfi G, Guidi GC. Acute variation of biochemical markers of muscle damage following a 21-km, half-marathon run. Scand J Clin Lab Invest. 2008;68:667–72.PubMedCrossRef Lippi G, Schena F, Salvagno GL, Montagnana M, Gelati M, Tarperi C, Banfi G, Guidi GC. Acute variation of biochemical markers of muscle damage following a 21-km, half-marathon run. Scand J Clin Lab Invest. 2008;68:667–72.PubMedCrossRef
18.
Zurück zum Zitat Chatzizisis YS, Misirli G, Hatzitolios AI, Giannoglou GD. The syndrome of rhabdomyolysis: Complications and treatment. Eur J Intern Med. 2008;19:568–74.PubMedCrossRef Chatzizisis YS, Misirli G, Hatzitolios AI, Giannoglou GD. The syndrome of rhabdomyolysis: Complications and treatment. Eur J Intern Med. 2008;19:568–74.PubMedCrossRef
19.
Zurück zum Zitat Hogan KJ, Vladutiu GD. Malignant hyperthermia-like syndrome and carnitine palmitoyltransferase II deficiency with heterozygous R503C mutation. Anesth Analg. 2009;109(4):1070–2.PubMedCrossRef Hogan KJ, Vladutiu GD. Malignant hyperthermia-like syndrome and carnitine palmitoyltransferase II deficiency with heterozygous R503C mutation. Anesth Analg. 2009;109(4):1070–2.PubMedCrossRef
20.
Zurück zum Zitat Vladutiu GD, Bennett MJ, Smail D, Wong LJ, Taggart RT, Lindsley HB. A variable myopathy associated with heterozygosity for the R503C mutation in the carnitine palmitoyltransferase II gene. Mol Genet Metab. 2000;70(2):134–41.PubMedCrossRef Vladutiu GD, Bennett MJ, Smail D, Wong LJ, Taggart RT, Lindsley HB. A variable myopathy associated with heterozygosity for the R503C mutation in the carnitine palmitoyltransferase II gene. Mol Genet Metab. 2000;70(2):134–41.PubMedCrossRef
21.
Zurück zum Zitat Yao D, Yao M, Yamaguchi M, Chida J, Kido H. Characterization of compound missense mutation and deletion of carnitine palmitoyltransferase II in a patient with adenovirus-associated encephalopathy. J Med Invest. 2011;58(3–4):210–8.PubMedCrossRef Yao D, Yao M, Yamaguchi M, Chida J, Kido H. Characterization of compound missense mutation and deletion of carnitine palmitoyltransferase II in a patient with adenovirus-associated encephalopathy. J Med Invest. 2011;58(3–4):210–8.PubMedCrossRef
Metadaten
Titel
Clinically symptomatic heterozygous carnitine palmitoyltransferase II (CPT II) deficiency
verfasst von
Dr. Pushpa Raj Joshi, PhD
Marcus Deschauer, MD
Stephan Zierz, MD
Publikationsdatum
01.12.2012
Verlag
Springer Vienna
Erschienen in
Wiener klinische Wochenschrift / Ausgabe 23-24/2012
Print ISSN: 0043-5325
Elektronische ISSN: 1613-7671
DOI
https://doi.org/10.1007/s00508-012-0296-9

Weitere Artikel der Ausgabe 23-24/2012

Wiener klinische Wochenschrift 23-24/2012 Zur Ausgabe

mitteilungen der gesellschaft der ärzte in wien

175 Jahre Gesellschaft der Ärzte in Wien

MUW resarcher of the month

Researcher of the Month